BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• 

  Vaccines

  FDA Pulls Valneva’s Chikungunya Shot From Market Citing ‘Serious Safety Concerns’

  Earlier this month, the FDA backed off on a pause in shipments of the chikungunya vaccine Ixchiq to older adults. Now, the regulator has reversed course.

  August 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Government

  HHS Will No Longer Recognize Employee Unions

  Thousands of employees across the Department of Health and Human Services are set to lose their collective bargaining rights in a move that American Federation of Government Employees national president Everett Kelley called “illegal and immoral.”

  August 25, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

  August 25, 2025

   · 

  15 min read
• Press Releases

  BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

  August 25, 2025

   · 

  3 min read
• Press Releases

  Spectral Medical Receives US$3 Million From Vantive

  August 25, 2025

   · 

  3 min read
• Press Releases

  BridgeBio to Present Additional Open-label Extension Data from ATTRibute-CM at ESC Congress 2025

  August 25, 2025

   · 

  2 min read
• Press Releases

  Propanc Biopharma Provides Shareholder Update

  August 25, 2025

   · 

  7 min read
• Press Releases

  Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference

  August 25, 2025

   · 

  1 min read
• Press Releases

  Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

  August 25, 2025

   · 

  7 min read
• Press Releases

  HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

  August 25, 2025

   · 

  7 min read